Press

Appointment of MAC Clinical Research to accelerate timeline of Phase I/IIa clinical trial of SPL026 for Major Depressive Disorder

Jun 2 • 4 min read

Quick Take Small Pharma Inc. has announced the expansion of its Phase I/IIa clinical trial for its DMT based treatment. This expansion comes with the appointment of MAC Clinical Research to assist in the development of the trial. Small Pharma Inc. (TSXV: DMT), a neuropharmaceutical company focused on psychedelic-assisted therapies, today announces the expansion of…

PharmaTher and TSRL Enter into Co-Development Agreement For Microneedle Patch Delivery Technology for Psychedelics and Antivirals

Jun 1 • 5 min read

Quick Take: PharmaTher and TSRL have entered into a co-development agreement to jointly develop a microneedle delivery patch for psychedelic therapy and antiviral medicine PharmaTher Holdings Ltd. (CSE: PHRM), a clinical-stage psychedelics biotech company and TSRL, Inc, a company focused on developing microneedle patches for the delivery of antivirals for the treatment of influenza, are…

MYND Life Sciences Inc. Establishes Scientific Advisory Board

May 28 • 5 min read

Quick Take: MYND Life Sciences announced the formation of its scientific advisory board. The SAB is comprised of international industry experts and pioneers in the fields of neuropsychopharmacology, genetics, immunology, psychedelics, medical research, and clinical trials. MYND Life Sciences Inc. (CSE: MYND), a drug research and development company focused on novel psychedelic drug development, diagnostic approaches…

NeonMind to Commence Trading on the OTCQB Venture Market

May 28 • 3 min read

NeonMind Biosciences Inc. announced that its shares will commence trading on the OTCQB® Venture Market on May 28, 2021, under the symbol “NMDBF”.

Leading Psychedelic Wellness Platform, Delic, Completes Acquisition of Complex Biotech Discovery Ventures Ltd.

May 27 • 7 min read

Quick Take Delic Holdings Inc. announced that it has acquired all of the issued and outstanding shares in the capital of Complex Biotech Discovery Ventures Ltd. Following closing, CBDV will change its name to “DELIC Labs” and will serve as the engine for the Delic platform. Delic Holdings Inc. (“DELIC” or the “Company“) (CSE: DELC), a psychedelic…

Pages: 123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435436437438439440441